Article
GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome.
Journal of clinical laboratory analysis - 1 Apr 2022
Liu Dongdong, Che Bangwei, Chen Pan, He Jun, Mu Yi, Chen Kehang, Zhang Wenjun, Xu Shenghan, Tang Kaifa
Abstract excerpt
BACKGROUND: Glutathione S-transferase (GSTs) gene polymorphism and metabolic syndrome (Mets) are generally considered to be risk factors for prostate cancer (PCa). However, this conclusion is still controversial. There is a close relationship between GSTs gene polymorphism and Mets. We suspect that the effect of GSTs gene polymorphism and Mets on PCa may be the result of their joint action. As a result, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.